We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byKelley York
Modified over 5 years ago
Very Long-Term Outcomes of the Carpentier-Edwards Perimount Aortic Valve in Patients Aged 60 or Younger Thierry Bourguignon, MD, Rym El Khoury, MD, Pascal Candolfi, PhD, Claudia Loardi, MD, Alain Mirza, MD, Julie Boulanger-Lothion, MD, Anne-Lorraine Bouquiaux-Stablo-Duncan, MD, Fabien Espitalier, MD, Michel Marchand, MD, Michel Aupart, MD The Annals of Thoracic Surgery Volume 100, Issue 3, Pages (September 2015) DOI: /j.athoracsur Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Kaplan-Meier estimates of overall (red) and valve-related survival with (blue) and without early death (green). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Kaplan-Meier estimates of cumulative incidence of the following valve-related complications: thromboembolism (blue), bleeding events (maroon), and endocarditis (yellow). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Kaplan-Meier estimates of freedom from reoperation (blue), structural valve deterioration (SVD; red), and explant as a result of structural valve deterioration (green). The expected valve durability (median survival time without structural valve deterioration) was 17.6 years. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 4 Competing risk analysis—cumulative risk of valve explantation (green) and death (red). Event-free survival is shown in blue. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W
Twenty-Five Year Experience With the St
High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients Danielle K. Farrington, MD, Patrick D. Kilgo,
Mechanical Versus Bioprosthetic Aortic Valve Replacement in Middle-Aged Adults: A Systematic Review and Meta-Analysis Dong Fang Zhao, BA, Michael Seco,
Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS
Long-Term Outcome and Valve Surgery for Infective Endocarditis in the Systematic Analysis of a Community Study Lauriane Pericart, MD, Laurent Fauchier,
Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective Vinod H. Thourani, MD, Richard Myung, MD, Patrick Kilgo,
Outcomes of Reintervention on the Autograft After Ross Procedure
Sreekumar Subramanian, MD, Sergey Leontyev, MD, Michael A
Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability? Tirone E. David, MD, Susan Armstrong, MS,
Jiro Esaki, MD, PhD, Bradley G. Leshnower, MD, Jose N
Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.
Spinal Cord Stimulation for Patients With Refractory Angina and Previous Coronary Surgery Elisabetta Lapenna, MD, Dino Rapati, MD, Paola Cardano, MS,
Long-Term Outcome of Patients With Complete Atrioventricular Septal Defect Combined With the Tetralogy of Fallot: Staged Repair Is Not Inferior to Primary Repair
Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M
Mitral Valve Repair Is Durable in Patients With Rheumatoid Arthritis
Operative Results and Outcomes in Children With Shone's Anomaly
Outcomes of Early Mitral Valve Reoperation in the Medicare Population
Andrea S. Wolf, MD, MPH, Scott J
Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M
© 2023 SlidePlayer.com Inc. All rights reserved.